Concepedia

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

Joseph J. Eron, Jürgen K. Rockstroh, Jacques Reynes, Jaime Andrade‐Villanueva, Jose Valdez Ramalho-Madruga, Linda‐Gail Bekker, Benjamin Young, Christine Katlama, José María Gatell-Artigas, José Ramón Arribas,

The Lancet Infectious Diseases · 2011 · 191 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents

Annals of Internal Medicine · 1998 · 5.2K citations

, , +17

Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells

Daria J. Hazuda, Peter J. Felock, Marc Witmer et al. · Science · 2000 · 1.1K citations

, , +16

Comparative analysis of two rates

Olli S. Miettinen, Markku Nurminen · Statistics in Medicine · 1985 · 1.1K citations

, , +16

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Roy T. Steigbigel, David A. Cooper, Princy Kumar et al. · New England Journal of Medicine · 2008 · 686 citations · Full text

, , +17

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Jeffrey L. Lennox, Edwin DeJesus, Adriano Lazzarin et al. · The Lancet · 2009 · 620 citations

, , +16